Meningioma secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Meningioma}} | {{Meningioma}} | ||
{{CMG}} {{AE}} {{IO}} {{HL}} | |||
==Overview== | |||
There are no established measures for the secondary prevention of meningioma. | |||
==Secondary Prevention== | |||
There are no established measures for the secondary prevention of meningioma. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category: | [[Category: (name of the system)]] | ||
Latest revision as of 14:47, 10 September 2019
Meningioma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Meningioma secondary prevention On the Web |
American Roentgen Ray Society Images of Meningioma secondary prevention |
Risk calculators and risk factors for Meningioma secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Haytham Allaham, M.D. [3]
Overview
There are no established measures for the secondary prevention of meningioma.
Secondary Prevention
There are no established measures for the secondary prevention of meningioma.